Celldex Therapeutics
CLDX
#4701
Rank
C$2.70 B
Marketcap
C$40.69
Share price
-0.51%
Change (1 day)
11.34%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.82 Billion

According to Celldex Therapeutics's latest financial reports the company has C$0.82 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$1.07 B88.31%
2023-12-31$C$0.56 B28.6%
2022-12-31$C$0.44 B-17.2%
2021-12-31$C$0.53 B100.26%
2020-12-31$C$0.26 B117.38%
2019-12-31$C$0.12 B-27.33%
2018-12-31$C$0.16 B-43.13%
2017-12-31$C$0.29 B-16.69%
2016-12-31$C$0.35 B-11.36%
2015-12-31$C$0.40 B63.84%
2014-12-31$C$0.24 B-27.85%
2013-12-31$C$0.34 B257.44%
2012-12-31$C$95.23 M36.24%
2011-12-31$C$69.9 M-7.07%
2010-12-31$C$75.22 M-3.08%
2009-12-31$C$77.61 M252.02%
2008-12-31$C$22.04 M-2052.67%
2007-12-31$-C$1.13 Million-144.88%
2006-12-31$C$2.51 M-89.65%
2005-12-31$C$24.32 M-47.28%
2004-12-31$C$46.13 M27.37%
2003-12-31$C$36.21 M-26.84%
2002-12-31$C$49.5 M-31.35%
2001-12-31$C$72.11 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
C$3.52 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-C$0.39 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.80 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$13.28 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.25 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C$3.85 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA